Physician

Abigail L Rose, M.D.

According to 2025 Medicare claims, Abigail Rose, M.D. (NPI: 1871551275) practices family practice in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is CAPITAL HEALTH MEDICAL GROUP (NPI: 1437516887; TIN: 810889110) and primary practice location at 08540-1530. Rose is affiliated with the Capital Health Accountable Care Organization, LLC (ACO ID: A2528), participating under the MSSP model.

Rose's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 61 traditional Medicare patients, billed 272 HCPCS/CPT codes, and received $27,175 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 525 prescription claims across 89 beneficiaries totaling $20,305 in drug costs, led by Rosuvastatin Calcium (Rosuvastatin Calcium). Open Payments data shows 5 records totaling $81. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $9,038 to $27,175. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $6,041 to $20,305. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	101	174	$9,038
2016	78	154	$8,638
2017	61	170	$10,450
2018	62	169	$10,626
2019	31	132	$8,844
2020	45	163	$9,981
2021	33	105	$10,727
2022	45	127	$13,811
2023	69	207	$23,892
2024	61	272	$27,175

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	77	110	$6,041
2016	66	130	$7,818
2017	73	196	$10,303
2018	75	375	$32,909
2019	48	383	$27,361
2020	53	323	$21,362
2021	45	285	$18,363
2022	73	337	$12,117
2023	97	487	$20,405
2024	89	525	$20,305

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	41	71	$153
G0439	Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit	18	18	$145
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	40	56	$105
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	33	59	$15

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rosuvastatin Calcium	Rosuvastatin Calcium	53	4,770	$856
Levothyroxine Sodium	Levothyroxine Sodium	21	1,871	$396
Atorvastatin Calcium	Atorvastatin Calcium	46	4,050	$337
Sertraline Hcl	Sertraline Hcl	13	1,170	$266
Gabapentin	Gabapentin	14	660	$242

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$81	GlaxoSmithKline, LLC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Abigail L. Rose, M.D.?

Tedicare shows public-source Medicare data for Abigail L. Rose, M.D. (NPI 1871551275), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Abigail L. Rose, M.D. have ACO affiliation data?

Abigail L. Rose, M.D. is shown with ACO affiliation data for Capital Health Accountable Care Organization, LLC (MSSP, ACO ID A2528).

What billing organization is linked to Abigail L. Rose, M.D.?

Abigail L. Rose, M.D. is linked to CAPITAL HEALTH MEDICAL GROUP (billing NPI 1437516887) in the available physician profile data.

Does Abigail L. Rose, M.D. have Open Payments data?

Abigail L. Rose, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.